Skip to content
HowShorted

Citius Pharmaceuticals, Inc. short interest in 2021

In 2021, Citius Pharmaceuticals, Inc.'s disclosed short interest ran from 2.04% of shares outstanding on 15 Jan 2021 to 8.32% on 31 Dec 2021, a change of +6.28 percentage points. The year's high was 15.79% on 30 Jun 2021 and its low 2.04% on 15 Jan 2021, averaging 9.32% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.64 days on 30 Nov 2021. Full history: Citius Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Citius Pharmaceuticals, Inc. in 2021

2021 in figures

Start of year
2.04% (15 Jan 2021)
End of year
8.32% (31 Dec 2021)
Change
+6.28 pp
High
15.79% (30 Jun 2021)
Low
2.04% (15 Jan 2021)
Average
9.32%
Highest days to cover
7.64 (30 Nov 2021)
SEC filings marked
7

Every report in 2021

Citius Pharmaceuticals, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20212.04%1.66
29 Jan 20214.35%1.39
12 Feb 20215.03%1.0010-Q filed
14 May 202110.76%1.9810-Q filed, results (8-K)
28 May 202111.68%4.35
15 Jun 202111.25%1.73
30 Jun 202115.79%1.18
15 Jul 202112.49%1.09
30 Jul 202110.75%5.15
13 Aug 20219.38%5.3810-Q filed, results (8-K)
31 Aug 20218.88%3.91
15 Sep 20219.87%4.20
30 Sep 20219.91%6.82
15 Oct 20219.71%7.02
29 Oct 20219.91%6.20
15 Nov 20219.22%7.48
30 Nov 20218.76%7.64
15 Dec 20218.98%6.2410-K filed, results (8-K)
31 Dec 20218.32%7.35

See also: Citius Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.